-
Study aim
-
To compare the short-term effects of Mulligan SNAG, Maitland, and Kaltenborn mobilization on pain, stiffness, disability, and lumbar range of motion in adults with chronic non specific lower back pain.
-
Design
-
A concealed, randomized, double-blinded, three-arm parallel-group clinical trial involving 48 participants (16 per group). Participants will be randomized equally into three groups and receive one treatment session. Outcomes will be assessed at baseline and 48 hours, including pain (NPRS), stiffness, disability, and lumbar range of motion. Participants and outcome assessors will be blinded
-
Settings and conduct
-
The study will be conducted at Hijaz Hospital, Lahore, Pakistan, using a randomized, three-group parallel design with baseline assessment, one treatment session, and 48-hour follow-up.
-
Participants/Inclusion and exclusion criteria
-
Adults aged 18–45 years of either sex with chronic low back pain lasting more than 12 weeks, baseline NPRS score of ≥3/10, and ability to attend the 48-hour follow-up will be included. Individuals who are pregnant, have previous spinal surgery, progressive neurological deficits, radiculopathy, red flags, or suspected serious pathology such as spinal fracture or malignancy will be excluded.
-
Intervention groups
-
Group A (Mulligan): Sustained pain-free lumbar glides with active symptomatic movement, 3 sets of 6 repetitions, with 60-second rest between sets. Group B (Maitland): Central and unilateral PA lumbar mobilization, 3 cycles of 60 seconds, with 60-second rest between cycles. Group C (Kaltenborn): Sustained lumbar traction and translatory glides, 3 applications of 30 seconds, with 60-second rest between applications. Each group will include 16 participants.
-
Main outcome variables
-
Numeric Pain Rating Scale (NPRS), Oswestry Disability Index (ODI), inclinometer, visual analogue scale (VAS).